Fall 2023 Vol. 13 Issue 03
-
From the Editor-in-Chief
Immunotherapy Gets PersonalTherapeutic vaccines can stimulate an immune response to cancer.
by William G. Nelson, MD, PhD
-
-
Your Cancer Guide
The Art of DeflectionCasual conversations can take unwelcome turns after you’ve been diagnosed with cancer. Here’s how to respond when people say the wrong things.
by Hester Hill Schnipper
-
Caregiving With Confidence
Addressing AngerCaregivers can take steps to encourage patients to have more healthy dialogue about strong emotions.
by K.J. Bannan
-
Policy Matters
Clinical Trials That Reflect Real-world PatientsA recent article discusses challenges and practical solutions for working toward more diverse and equitable oncology clinical trials.
by Nicholas Warren, PhD
-
Immunotherapy: When Is Sooner Better Than Later?Researchers explore whether giving immunotherapy before surgery and other treatments could improve outcomes for people with cancer.
by Stephen Ornes
-
Living With Chronic Blood CancerThanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Making Clinical Trials EasierClinical trials can be hard to find, challenging to get into and difficult to complete. Patient advocates and their supporters want to change that.
by Cameron Walker
-
Survivor Profile
Changing CourseInitially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
-
-
Q&A
Pulling Back the Research CurtainJessica Wapner looks back on the scientific discoveries that transformed outcomes for chronic myelogenous leukemia.
by Marci A. Landsmann
-
-
Get Involved
A Bountiful HarvestFood for the Cure provides fresh produce to people with cancer.
by Thomas Celona
-
Facts and Stats
Will We Make the Moonshot?As the Cancer Moonshot aims to cut cancer deaths in half by 2047, researchers identify strategies to hit that benchmark.
by Thomas Celona
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
